Generic pregabalin; current situation and implications for health authorities, generics and biosimilars manufacturers in the future
Naslov
Generic pregabalin; current situation and implications for health authorities, generics and biosimilars manufacturers in the future
Identifikator
/unibl/sci/idNaucniRad:16548
Tip
Pronađite slične unoseAcademic Article
Datum
Pronađite slične unose2015-05
Bibliografski citat
B. Godman, M. Wilcock, A. Martin, S. Bryson, C. Baumgartel, T. Bochenek, W. de Bruyn, L. Sović-Brkičić, M. D'Agata, A. Fogele, A. Coma Fuste, J. Fraeyman, J. Furst, K. Garuoliene, H. Herholz, M. Hoffman, S. Jayathissa, H. Kwon, I. Langner, M. Kalaba, E. Magnusson, E. Anderse Karlssen, O. Laius, V. Marković Peković, E. Magnusson, S. McTaggart, H. Pedersen, J. Piessnegger, A. Ringerud, G. Selke, C. Sermet, K. Schiffers, P. Skiold, D. Tomek, A. Viksna, A. Vitry, C. Zara, R. Malmstrom, Generic pregabalin; current situation and implications for health authorities, generics and biosimilars manufacturers in the future, Generics and Biosimilars Initiative Journal, Vol. 4, No. 3, pp. 125 - 135, May, 2015
Početna stranica
125
Krajnja stranica
135
Je dio
Generics and Biosimilars Initiative Journal
2033-6403
Lista autora
Position: 1867 (40 views)